期刊
JOURNAL OF SURGICAL ONCOLOGY
卷 101, 期 4, 页码 305-314出版社
WILEY-LISS
DOI: 10.1002/jso.21483
关键词
gastric cancer; neoadjuvant therapy; chemotherapy; gastrectomy; cytology
Treatment of gastric cancer has evolved with the advent of randomized trials demonstrating chemotherapeutic agents with efficacy in advanced disease. Level I evidence Supports delivering chemotherapy in the neoadjuvant settings the data shows improvement in progression-free and overall survival. A clinical response to therapy is associated with improved R0 resection rates, pathologic response. and outcome in patients with locally advanced disease. Early assessment of metabolic response to therapy can potentially be utilized to tailor treatment. J. Surg. Oncol. 2010; 101:305-314. (C) 2010 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据